Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Angelo Romasanta"'
Autor:
Gozal Ahmadova, Angelo Romasanta, Mary J. Benner, Nelson Phillips, Jonathan D. Wareham, Gino Cattani, Bart Clarysse, Paola Criscuolo, Dirk Deichmann, Stefano Benigni, Denise Falchetti, Simone Ferriani, Markus Perkmann, Daan Alexander Stam, Jana Thiel, Qi Zhang
Publikováno v:
Academy of Management Proceedings. 2022
Publikováno v:
Academy of Management Proceedings. 2022
Autor:
J.E. van Muijlwijk-Koezen, Angelo Romasanta, I.J.P. de Esch, Wolfgang Jahnke, P.C. van der Sijde, Martine J. Smit
Publikováno v:
Romasanta, A K S, van der Sijde, P C, Smit, M J, de Esch, I J P, Jahnke, W & van Muijlwijk-Koezen, J E 2020, ' Career development in fragment-based drug discovery ', Drug Discovery Today: Technologies, vol. 37, pp. 107-116 . https://doi.org/10.1016/j.ddtec.2020.10.001
Drug Discovery Today: Technologies, 37, 107-116. Elsevier Limited
Drug Discovery Today: Technologies, 37, 107-116. Elsevier Limited
The pharmaceutical industry is highly reliant on researchers who not only possess the technical knowledge but also the professional skills to collaborate in drug development. To prepare future practitioners to thrive in this interdisciplinary environ
Publikováno v:
Romasanta, A K S, van der Sijde, P & van Muijlwijk-Koezen, J 2020, ' Innovation in pharmaceutical R &D : mapping the research landscape ', Scientometrics, vol. 125, no. 3, pp. 1801-1832 . https://doi.org/10.1007/s11192-020-03707-y
Scientometrics, 125(3), 1801-1832. Springer Netherlands
Scientometrics, 125(3), 1801-1832. Springer Netherlands
In response to the increasing number and breadth of innovation studies on the pharmaceutical industry, we mapped the literature to show the trends in recent research and to indicate areas for further research. In the first phase, we analyzed articles
Publikováno v:
Romasanta, A K S, van der Sijde, P & de Esch, I J P 2022, ' Absorbing knowledge from an emerging field : The role of interfacing by proponents in big pharma ', Technovation, vol. 110, no. February, 102363 . https://doi.org/10.1016/j.technovation.2021.102363
Technovation, 110(February):102363. Elsevier Limited
Technovation, 110(February):102363. Elsevier Limited
Engaging with knowledge from an emerging field, with its promises and limitations still uncertain, can be challenging for incumbent firms. Proponents of novel technologies within these firms then play an important role in bridging the developments in
Autor:
Angelo Romasanta, Jonathan Wareham, Pablo Garcia Tello, Laia Pujol Priego, Thomas Wareham Mathiassen, Markus Nordberg
Publikováno v:
Wareham, J, Pujol Priego, L, Romasanta, A K, Mathiassen, T W, Nordberg, M & Tello, P G 2022, ' Systematizing serendipity for big science infrastructures : The ATTRACT project ', Technovation, vol. 116, 102374 . https://doi.org/10.1016/j.technovation.2021.102374
Big Science Research Infrastructures (BSRIs) are tremendous sources of ‘deep-tech’ with the potential to foment alternative commercial applications in diverse industries. Yet, cultivating novel applications of BSRI technologies is not straightfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::535eb289bd007dedf3cae648d25d10bb
https://orbit.dtu.dk/en/publications/8353ecdf-6fbc-43a4-a0d1-606c55e88838
https://orbit.dtu.dk/en/publications/8353ecdf-6fbc-43a4-a0d1-606c55e88838
Autor:
Angelo Romasanta, Jonathan Wareham
Angelo Romasanta and Jonathan Wareham did a presentation entitled "FAIR Data through a federated cloud infrastructure: exploring the Science Mesh." The presentation is based on a paper authored by both speakers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2ca39db1348a5ea9951e1ba762ab1d
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
CrystEngComm. 19:653-660
New binary and ternary solid solutions formed by p-chlorobenzyl alcohol (p-ClBA), p-bromobenzyl alcohol (p-BrBA) and their quasi-isostructural compound p-methylbenzyl alcohol (p-MeBA) have been prepared and characterized by DSC and powder X-ray diffr
Autor:
Iwan J. P. de Esch, Roderick E. Hubbard, Peter van der Sijde, Iina Hellsten, Angelo Romasanta, Jacqueline E. van Muijlwijk-Koezen, György M. Keserü
Publikováno v:
Romasanta, A K S, van der Sijde, P, Hellsten, I, Hubbard, R E, Keseru, G M, van Muijlwijk-Koezen, J & de Esch, I J P 2018, ' When fragments link : a bibliometric perspective on the development of fragment-based drug discovery ', Drug Discovery Today, vol. 23, no. 9, pp. 1596-1609 . https://doi.org/10.1016/j.drudis.2018.05.004
Drug discovery today, 23(9), 1596-1906. Elsevier
Drug Discovery Today, 23(9), 1596-1609. Elsevier Limited
Drug Discovery Today
Drug discovery today, 23(9), 1596-1906. Elsevier
Drug Discovery Today, 23(9), 1596-1609. Elsevier Limited
Drug Discovery Today
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8535b7f44c1a20074286c5448fa477
https://research.vu.nl/en/publications/aa16c792-8ca9-48a3-a6e0-b3adfb3ad045
https://research.vu.nl/en/publications/aa16c792-8ca9-48a3-a6e0-b3adfb3ad045